The strength of immune responses after the first dose of COVID-19 vaccines could make or break this strategy and policy makers need to be able to adapt.
What COVID-19 vaccine should I get? Whichever one you are offered, say experts
First and foremost, the goal is to keep people out of hospitals. The good news is all of the currently approved vaccines do just that.
Russian COVID-19 vaccine shows 91.6% efficacy in phase 3 trial
Russia’s Sputnik V coronavirus vaccine gives around 92% protection against COVID-19, results published in The Lancet reveal.
Vaccinating the most vulnerable first may not have the greatest impact on COVID-19, new model suggests
A new simulator can accurately model COVID-19 and the effects of different mitigation strategies, which researchers say could help guide new policies to combat the pandemic.
New method to assist fast-tracking of vaccines for pre-clinical tests
Nvel tuberculosis vaccine demonstrated strong immune response in mice.
A new biosensor detects COVID-19 antibodies in 10-12 seconds
The testing platform identifies the presence of two antibodies in microliter samples of blood.
Oxford–AstraZeneca COVID-19 vaccine shown to be safe and effective
The results of the company’s COVID-19 vaccine clinical trials are the first to be published in a peer-reviewed journal.
Moderna’s COVID-19 vaccine shows 95% efficacy
US company second to report impressive efficacy for its COVID-19 vaccine candidate.
Trial COVID-19 vaccine shown to be 90% effective
Pfizer and BioNTech announce vaccine candidate against COVID-19 achieved success in first interim analysis from Phase 3 study.
Can the pneumonia vaccine protect against COVID-19?
Where pneumococcal vaccination rates are high, COVID-19 cases are low and vice-versa.